Baxter International Inc
BAX:NYSE
| Last | Change / % Change | Dividend Yield | Volume |
| 60.69 | -0.27 -0.44% | 2.95% | 2,726,001 |
Market data is delayed by at least 20 minutes.
Latest News Headlines for Baxter International Inc
Watch for Baxter International to Potentially Rebound After Falling 2.17% Yesterday
Baxter International (NYSE:BAX) traded in a range yesterday that spanned from a low of $60.24 to a high of $61.63. Yesterday, the shares fell 2.2%, which took the trading range below the 3-day low of $61.08 on volume of 3.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean revision.
Watch for Baxter International to Potentially Rebound After Falling 2.17% Yesterday
Baxter International (NYSE:BAX) traded in a range yesterday that spanned from a low of $60.24 to a high of $61.63. Yesterday, the shares fell 2.2%, which took the trading range below the 3-day low of $61.08 on volume of 3.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean revision.
Baxter International Makes a Move: Down 2.3%
View more recent headlinesBaxter International (NYSE:BAX) is one of today's biggest movers, down 2.3% to $60.40. The Dow Jones Industrial Average is now trading 0.6% lower to 13,496 and the S&P; is trading 0.9% lower to 1,444.
Company Background
Baxter International Inc. (Baxter) is a global, diversified healthcare company. Baxter, through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The Company operated in two segments: BioScience and Medication Delivery. It is engaged in the medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. These products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, clinical and medical research laboratories, and by patients at home under physician supervision. In February 2012, it acquired Synovis Life Technologies, Inc. In November 2011, it acquired Baxa Corporation. In April 2012, it purchased SIGMA International General Medical Apparatus, LLC.
Bid/Size -- / -- | Ask/Size -- / -- |
Price Open 61.12 | Previous Close 60.96 |
Day High 61.18 | Day Low 60.49 |
52wk High/Date 61.98 / 10/5/2012 | 52wk Low/Date 47.5518 / 12/19/2011 |
Beta (5 Yr) 0.5 | Market Capitalization 33.2B |
Shares Outstanding 547.2M | Volatility Avg 20.07 |
Avg Vol(10 day) 2.5M | P/E Ratio 14.9x |
EPS(TTM) 4.07 | Yield 2.95% |
Dividend Announcement 7/25/2012 | Ex-Date 9/5/2012 |
Payable 0.45 - QRTR | Payable Date 10/1/2012 |
Date of Record 9/7/2012 | |
Last Trade as of 10/12/2012 4:00 PM ET | |
BAX Baxter International Inc vs. Peers
| Peers | |
|---|---|
BAX Baxter International Inc | 23.20% |
Boston Scientific Corporation | 4.49% |
Johnson & Johnson | 3.64% |
Abbott Laboratories | 23.46% |
Pfizer Inc. | 16.08% |
BAX Baxter International Inc | 2.97% |
Boston Scientific Corporation | -- |
Johnson & Johnson | 3.59% |
Abbott Laboratories | 2.94% |
Pfizer Inc. | 3.50% |
BAX Baxter International Inc | -0.44% |
Boston Scientific Corporation | -0.18% |
Johnson & Johnson | 0.00% |
Abbott Laboratories | -0.20% |
Pfizer Inc. | 0.00% |